PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Epilia: Epilepsy and Community10.35615/epilia.2022.0031220224113-19Epilepsy and COVID-19: Recent Findings and ConsiderationsHyun Kyung Kimhttp://jepilia.org/upload/pdf/epilia-2022-00312.pdf, http://jepilia.org/journal/view.php?doi=10.35615/epilia.2022.00312, http://jepilia.org/upload/pdf/epilia-2022-00312.pdf
Epilepsy & Behavior10.1016/j.yebeh.2020.1071222020108107122Epilepsy and COVID-19: Associations and important considerationsNaoto Kurodahttps://api.elsevier.com/content/article/PII:S1525505020303012?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525505020303012?httpAccept=text/plain
Epilepsy & Behavior10.1016/j.yebeh.2020.1071982020111107198Mental health considerations for patients with epilepsy during COVID-19 crisisNaoto Kurodahttps://api.elsevier.com/content/article/PII:S1525505020303772?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525505020303772?httpAccept=text/plain
Epilepsy & Behavior Reports10.1016/j.ebr.2021.100498202116100498Considerations for continuing diet therapy in patients with epilepsy during the COVID-19 pandemic: A scoping reviewNaoto Kuroda, Ayataka Fujimotohttps://api.elsevier.com/content/article/PII:S2589986421000721?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2589986421000721?httpAccept=text/plain
Epilepsy & Behavior10.1016/j.yebeh.2020.1076822021115107682Meta-analysis of EEG findings in patients with COVID-19Takafumi Kubota, Prasannakumar Kanubhai Gajera, Naoto Kurodahttps://api.elsevier.com/content/article/PII:S1525505020308623?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525505020308623?httpAccept=text/plain
Epilepsy & Behavior10.1016/j.yebeh.2021.1082782021123108278Anesthesia considerations for patients with epilepsy: Findings of a qualitative study in the Palestinian practiceMohammad Jaber, Ramzi Shawahna, Majd Abu-Issa, Faris Radwan, Mohammad Dweikhttps://api.elsevier.com/content/article/PII:S1525505021005394?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525505021005394?httpAccept=text/plain
Neurological Sciences10.1007/s10072-020-04549-520204182005-2011Management of COVID-19 in people with epilepsy: drug considerationsAli A. Asadi-Pooya, Armin Attar, Mohsen Moghadami, Iman Karimzadehhttps://link.springer.com/content/pdf/10.1007/s10072-020-04549-5.pdf, https://link.springer.com/article/10.1007/s10072-020-04549-5/fulltext.html, https://link.springer.com/content/pdf/10.1007/s10072-020-04549-5.pdf
Epilepsy & Behavior10.1016/j.yebeh.2021.1077852021116107785Epilepsy and COVID-19: Updated evidence and narrative reviewNaoto Kurodahttps://api.elsevier.com/content/article/PII:S1525505021000196?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525505021000196?httpAccept=text/plain
Epilepsy Research10.1016/j.eplepsyres.2021.1066892021176106689Virtual epilepsy clinics – A Canadian Comprehensive Epilepsy Center experience pre-COVID and during the COVID-19 pandemic periodSallya Aleboyeh, Ramana Appireddy, Gavin P. Winston, Lysa Boisse Lomax, Garima Shuklahttps://api.elsevier.com/content/article/PII:S092012112100142X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092012112100142X?httpAccept=text/plain
Epilepsy & Behavior10.1016/j.yebeh.2021.1080722021121108072Estimated effect of COVID-19 vaccine in people with epilepsyNaoto Kurodahttps://api.elsevier.com/content/article/PII:S1525505021003061?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525505021003061?httpAccept=text/plain